US 11623923
Uracil compound as c-MET/AXL inhibitor
granted A61PA61P35/00A61P35/02
Quick answer
US patent 11623923 (Uracil compound as c-MET/AXL inhibitor) held by Medshine Discovery Inc. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P35/04